Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Condition: Gastroenteropancreatic Neuroendocrine Tumor Intervention: Drug: Somatostatin analog Sponsors: University Hospital, Antwerp; Erasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development; Belgium Health Care Knowledge Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials